RE:RE:RE:Picked up a few more sharesGW is definately ahead in respect to EPI...cant help but wonder if CRDL gets orphan designation for acute myocarditis, larger addressible market. Even if pharma scoops this up for $1B thats 10x today. Cash indicates this company is going to be here for at least 2 more years.